Abiomed Inc (ABMD) Inventory Turnover Ratio, from second quarter 2023 to second quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Abiomed Inc   (NASDAQ: ABMD)
 

Abiomed Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2023, Abiomed Inc 's inventory turnover ratio sequentially decreased to 2.1 in the second quarter 2022, unsurprisingly, as the Abiomed Inc markets continue to deteriorate, and ABMD's faces growing challenges to bring down its inventories. Abiomed Inc 's average inventory processing period in the Sep 30 2022 quarter, has increased to 174 days, from 171 days, in the Jun 30 2022 quarter.

Within Healthcare sector 252 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1525 in the first quarter 2023, to 1539.

ABMD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Abiomed Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABMD Inventory Turnover Ratio (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter		 (Sep 30 2021)
II. Quarter
Y / Y Inventory Growth 18.9 % 14 % 15.94 % 9.4 % 3.34 %
Y / Y Cost of Sales Growth 11.38 % 16.46 % 11.67 % 15.85 % 13.3 %
Inventory Turnover Ratio (TTM) 2.1 2.14 2.13 2.14 2.12
ABMD's Total Ranking # 1539 # 1525 # 1521 # 1670 # 1673
Average inventory processing period 174 171 172 170 172
Seq. Inventory Growth 7.2 % 1.48 % 4.19 % 4.9 % 2.78 %
Seq. Cost of Sales Growth -7.12 % 2.27 % 8.04 % 8.52 % -2.88 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 99
Healthcare Sector # 253
Overall Market # 1539

Inventory Turnover Ratio Statistics
High Average Low
2.77 2.17 1.67
(Sep 30 2014)   (Jun 30 2020)



ABMD Company Profile >> Back to ABMD Efficiency Comparisons >> Compare ABMD Inventory Turnover Ratio to its Competitors

Financial Statements
Abiomed Inc 's Inventories $ 102 Millions Visit ABMD's Balance sheet
Abiomed Inc 's Cost of Revenues TTM $ 201 Millions Visit ABMD's Income Statement
What are ABMD's Sales? Visit ABMD's Sales by Segment

Other Inventory Turnover Ratios
Abiomed Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ABMD's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ABMD's Competitors
Inventory Turnover Ratio for ABMD's Suppliers
Inventory Turnover Ratio for ABMD's Customers

You may also want to know
ABMD's Sales Growth Rates ABMD's Pe Price to earnings ratio ABMD's Receivables Turnover Ratio ABMD's Stock Quote
ABMD's Net Income Growth Rates ABMD's Ps Price to Sales ratio ABMD's Sales per Employee ABMD's Asset Turnover Ratio
ABMD's Net Margin ABMD's Pb Price to Book ratio ABMD's Financial Strength Ratios ABMD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2022 Inventories at quarter ending Sep 30 2022
Sunwin Stevia International Inc.  5.39 $ 29.273  Millions$ 5  Millions
Abbvie Inc   5.33 $ 17,564.000  Millions$ 3,295  Millions
Integer Holdings Corporation  5.31 $ 973.732  Millions$ 183  Millions
Ufp Technologies Inc   5.28 $ 238.842  Millions$ 45  Millions
Collegium Pharmaceutical Inc   5.16 $ 309.749  Millions$ 60  Millions
Nexgel Inc   5.11 $ 1.727  Millions$ 0  Millions
Harrow Inc   5.11 $ 24.298  Millions$ 5  Millions
Lftd Partners Inc   5.05 $ 33.003  Millions$ 7  Millions
Vyant Bio Inc   4.93 $ 1.819  Millions$ 0  Millions
Steris Plc  4.90 $ 2,110.413  Millions$ 431  Millions
Exact Sciences Corporation  4.88 $ 546.300  Millions$ 112  Millions
Steris Plc  4.86 $ 2,616.796  Millions$ 539  Millions
Catalent Inc   4.83 $ 3,375.300  Millions$ 700  Millions
T2 Biosystems Inc   4.79 $ 22.733  Millions$ 5  Millions
Henry Schein Inc   4.77 $ 8,795.018  Millions$ 1,843  Millions
Bristol myers Squibb Company  4.71 $ 9,900.000  Millions$ 2,104  Millions
Incyte Corporation  4.68 $ 191.708  Millions$ 41  Millions
Chembio Diagnostics Inc   4.67 $ 51.974  Millions$ 11  Millions
Organogenesis Holdings Inc   4.62 $ 110.546  Millions$ 24  Millions
Zeo Scientifix Inc   4.58 $ 0.754  Millions$ 0  Millions
Ginkgo Bioworks Holdings Inc   4.58 $ 29.786  Millions$ 7  Millions
Gilead Sciences Inc   4.55 $ 6,888.000  Millions$ 1,514  Millions
Aquestive Therapeutics Inc   4.50 $ 22.947  Millions$ 5  Millions
Tandem Diabetes Care Inc   4.45 $ 379.519  Millions$ 85  Millions
Precision Optics Corporation Inc   4.42 $ 12.413  Millions$ 3  Millions
Horizon Therapeutics Public Limited Company  4.35 $ 920.919  Millions$ 212  Millions
Idexx Laboratories Inc  4.34 $ 1,366.106  Millions$ 315  Millions
Invacare Holdings Corporation  4.33 $ 596.174  Millions$ 138  Millions
Perspective Therapeutics Inc   4.32 $ 5.131  Millions$ 1  Millions
Enzo Biochem Inc  4.30 $ 64.502  Millions$ 15  Millions

Date modified: 2026-08-29T17:31:38+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.